Episode 1: Setting the Record Straight on Obesity and Type 2 Diabetes Medications

Resources for the Community:
___________________________________________________________________

Ro - Telehealth for GLP1 weight management 

https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55

Ro GLP-1 Insurance Checker 

https://ro.co/weight-loss/glp1-insurance-checker/

Ro GLP-1 Supply and Shortage Tracker 

https://ro.co/weight-loss/supply-tracker/

Learn more about Obesity 

https://www.obesityaction.org/
______________________________________________________________________

In this episode, we discuss the common misconceptions surrounding prescribing GLP1 medications such as Ozempic, Victoza, and Mounjaro, which were initially designed to treat type 2 diabetes and are now being prescribed to treat the disease of obesity. Dr. Michael Albert, an obesity specialist, joins us to set the record straight.
______________________________________________________________________

⭐️Mounjaro Stanley⭐️

griffintumblerco.Etsy.com

Use code PODCAST10 for $ OFF
______________________________________________________________________

Join this channel to get access to perks:

   / @theplussidez
______________________________________________________________________

#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide  #GLP1 #Obesity #zepbound #wegovy 

Support the show

Kim Carlos, Executive Producer

TikTok

https://www.tiktok.com/@dmfkim?is_from_webapp=1&sender_device=pc

Instagram

https://www.instagram.com/dmfkimonmounjaro?igsh=aDF6dnlmbHBoYmJn&utm_source=qr

Kat Carter, Associate Producer

TikTok

https://www.tiktok.com/@katcarter7?is_from_webapp=1&sender_device=pc

Instagram

https://www.instagram.com/mrskatcarter?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw==